Search research articles
Contact Us
Filters
Showing results (321-330 of 362) with videos related to
Page
of 37
Sort By:
Nature Communications
|
September 30, 2025
Tumor immune dynamics and long-term clinical outcome of stage IIIA NSCLC patients treated with neoadjuvant chemoimmunotherapy
Dominic Schmid, Bettina Sobottka, Massimiliano Manzo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 25, 2023
European Epidemiology of Pleural Mesothelioma-Real-Life Data From a Joint Analysis of the Mesoscape Database of the European Thoracic Oncology Platform and the European Society of Thoracic Surgery Mesothelioma Database
Isabelle Opitz, Andrea Bille, Urania Dafni, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 1, 2022
Safety of First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC: A Pooled Analysis of CheckMate 227, CheckMate 568, and CheckMate 817
Luis G Paz-Ares, Tudor-Eliade Ciuleanu, Adam Pluzanski, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 27, 2019
Spatial and Temporal Heterogeneity of Panel-Based Tumor Mutational Burden in Pulmonary Adenocarcinoma: Separating Biology From Technical Artifacts
Daniel Kazdal, Volker Endris, Michael Allgäuer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 5, 2023
Systemic and Intracranial Outcomes With First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC and Baseline Brain Metastases From CheckMate 227 Part 1
Martin Reck, Tudor-Eliade Ciuleanu, Jong-Seok Lee, et al.
Clinical Lung Cancer
|
May 14, 2024
Brief Report: Impact of Anti-Cancer Treatments on Outcomes of COVID-19 in Patients With Thoracic Cancers: A CCC19 Registry Analysis
Amit A Kulkarni, Cassandra Hennessy, Grace Wilson, et al.
JCO Precision Oncology
|
February 12, 2025
Prevalence and Clinical Association of CD276 (B7-H3) Expression in Pleural Mesothelioma: Results From the European Thoracic Platform Mesoscape Project
Martina Haberecker, Jan H Rüschoff, Charitini Andriakopoulou, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 19, 2020
Treatment Guidance for Patients With Lung Cancer During the Coronavirus 2019 Pandemic
Anne-Marie C Dingemans, Ross A Soo, Abdul Rahman Jazieh, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 23, 2023
Disparities in outcomes between Black and White patients in North America with thoracic malignancies and COVID-19 infection (TERAVOLT)
Laura Burns, Chih-Yuan Hsu, Jennifer G Whisenant, et al.
The New England Journal of Medicine
|
June 22, 2017
First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer
David P Carbone, Martin Reck, Luis Paz-Ares, et al.
Page
of 37
Search research articles
Search
Showing results (321-330 of 362) with videos related to
Sort By:
Page
of 37
Nature Communications
|
September 30, 2025
Tumor immune dynamics and long-term clinical outcome of stage IIIA NSCLC patients treated with neoadjuvant chemoimmunotherapy
Dominic Schmid, Bettina Sobottka, Massimiliano Manzo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 25, 2023
European Epidemiology of Pleural Mesothelioma-Real-Life Data From a Joint Analysis of the Mesoscape Database of the European Thoracic Oncology Platform and the European Society of Thoracic Surgery Mesothelioma Database
Isabelle Opitz, Andrea Bille, Urania Dafni, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 1, 2022
Safety of First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC: A Pooled Analysis of CheckMate 227, CheckMate 568, and CheckMate 817
Luis G Paz-Ares, Tudor-Eliade Ciuleanu, Adam Pluzanski, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 27, 2019
Spatial and Temporal Heterogeneity of Panel-Based Tumor Mutational Burden in Pulmonary Adenocarcinoma: Separating Biology From Technical Artifacts
Daniel Kazdal, Volker Endris, Michael Allgäuer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 5, 2023
Systemic and Intracranial Outcomes With First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC and Baseline Brain Metastases From CheckMate 227 Part 1
Martin Reck, Tudor-Eliade Ciuleanu, Jong-Seok Lee, et al.
Clinical Lung Cancer
|
May 14, 2024
Brief Report: Impact of Anti-Cancer Treatments on Outcomes of COVID-19 in Patients With Thoracic Cancers: A CCC19 Registry Analysis
Amit A Kulkarni, Cassandra Hennessy, Grace Wilson, et al.
JCO Precision Oncology
|
February 12, 2025
Prevalence and Clinical Association of CD276 (B7-H3) Expression in Pleural Mesothelioma: Results From the European Thoracic Platform Mesoscape Project
Martina Haberecker, Jan H Rüschoff, Charitini Andriakopoulou, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 19, 2020
Treatment Guidance for Patients With Lung Cancer During the Coronavirus 2019 Pandemic
Anne-Marie C Dingemans, Ross A Soo, Abdul Rahman Jazieh, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 23, 2023
Disparities in outcomes between Black and White patients in North America with thoracic malignancies and COVID-19 infection (TERAVOLT)
Laura Burns, Chih-Yuan Hsu, Jennifer G Whisenant, et al.
The New England Journal of Medicine
|
June 22, 2017
First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer
David P Carbone, Martin Reck, Luis Paz-Ares, et al.
Page
of 37